Cargando…

Distribution patterns of tau pathology in progressive supranuclear palsy

Progressive supranuclear palsy (PSP) is a 4R-tauopathy predominated by subcortical pathology in neurons, astrocytes, and oligodendroglia associated with various clinical phenotypes. In the present international study, we addressed the question of whether or not sequential distribution patterns can b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovacs, Gabor G., Lukic, Milica Jecmenica, Irwin, David J., Arzberger, Thomas, Respondek, Gesine, Lee, Edward B., Coughlin, David, Giese, Armin, Grossman, Murray, Kurz, Carolin, McMillan, Corey T., Gelpi, Ellen, Compta, Yaroslau, van Swieten, John C., Laat, Laura Donker, Troakes, Claire, Al-Sarraj, Safa, Robinson, John L., Roeber, Sigrun, Xie, Sharon X., Lee, Virginia M.- Y., Trojanowski, John Q., Höglinger, Günter U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360645/ https://www.ncbi.nlm.nih.gov/pubmed/32383020 http://dx.doi.org/10.1007/s00401-020-02158-2

Ejemplares similares

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020)

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
por: Kurz, Carolin, et al.
Publicado: (2016)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Tau deposition patterns are associated with functional connectivity in primary tauopathies
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
por: Jabbari, Edwin, et al.
Publicado: (2018)

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy
por: Klietz, Martin, et al.
Publicado: (2021)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

Multireceptor fingerprints in progressive supranuclear palsy
por: Chiu, Wang Zheng, et al.
Publicado: (2017)

Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
por: Marx, Svenja, et al.
Publicado: (2012)

Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2022)

The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers
por: Respondek, Gesine, et al.
Publicado: (2022)

Assessment of (18)F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2020)

Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy
por: Abos, Alexandra, et al.
Publicado: (2019)

Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
por: Weber, Axel, et al.
Publicado: (2018)

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
por: Simoes, Fabio A., et al.
Publicado: (2022)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

Axonal injury is detected by βAPP immunohistochemistry in rapid death from head injury following road traffic collision
por: Al-Sarraj, Safa, et al.
Publicado: (2022)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Identifying the genetic components underlying the pathophysiology of movement disorders
por: Ezquerra, Mario, et al.
Publicado: (2011)

Presentations and mechanisms of CNS disorders related to COVID-19
por: Bodro, Marta, et al.
Publicado: (2020)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Identification of common variants influencing risk of the tauopathy Progressive Supranuclear Palsy
por: Höglinger, Günter U., et al.
Publicado: (2011)

Spinal cord injury as an indicator of abuse in forensic assessment of abusive head trauma (AHT)
por: Colombari, Michela, et al.
Publicado: (2021)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
por: Roemer, Shanu F., et al.
Publicado: (2022)

The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease
por: Stutzbach, Lauren D, et al.
Publicado: (2013)

Simulated surgical-type cerebral biopsies from post-mortem brains allows accurate neuropathological diagnoses in the majority of neurodegenerative disease groups
por: King, Andrew, et al.
Publicado: (2013)

Hemichorea as Presentation of Acute Cortical Ischemic Stroke. Case Series and Review of the Literature
por: Carbayo, Álvaro, et al.
Publicado: (2020)

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2015)

Changes of Phenotypic Pattern in Functional Movement Disorders: A Prospective Cohort Study
por: Tomić, Aleksandra, et al.
Publicado: (2020)

Gait alterations in Parkinson’s disease at the stage of hemiparkinsonism—A longitudinal study
por: Marković, Vladana, et al.
Publicado: (2022)

Clinical Approach to Supranuclear Brainstem Saccadic Gaze Palsies
por: Lloyd-Smith Sequeira, Alexandra, et al.
Publicado: (2017)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
por: Pereira, Marta F, et al.
Publicado: (2022)

Impaired perception of surface tilt in progressive supranuclear palsy
por: Dale, Marian L., et al.
Publicado: (2017)

ALS-FUS pathology revisited: singleton FUS mutations and an unusual case with both a FUS and TARDBP mutation
por: King, Andrew, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3qmfi76dhfcldqom89rt40rvdb